» Articles » PMID: 22701231

Malignant Hyperthermia: Dantrolene Sodium - A Must Have

Overview
Specialty Anesthesiology
Date 2012 Jun 16
PMID 22701231
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent.

Zhang X, Cheng Q, Li L, Shangguan L, Li C, Li S Theranostics. 2019; 9(11):3107-3121.

PMID: 31244944 PMC: 6567959. DOI: 10.7150/thno.34947.


Skeletal Muscle Thermogenesis and Its Role in Whole Body Energy Metabolism.

Periasamy M, Herrera J, Reis F Diabetes Metab J. 2017; 41(5):327-336.

PMID: 29086530 PMC: 5663671. DOI: 10.4093/dmj.2017.41.5.327.

References
1.
Larach M, Gronert G, Allen G, Brandom B, Lehman E . Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg. 2010; 110(2):498-507. DOI: 10.1213/ANE.0b013e3181c6b9b2. View

2.
Glahn K, Ellis F, Halsall P, Muller C, Snoeck M, Urwyler A . Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth. 2010; 105(4):417-20. DOI: 10.1093/bja/aeq243. View

3.
Anderson T, Drummond D, Breed A, Taylor C . Malignant hyperthermia in myelomeningocele: a previously unreported association. J Pediatr Orthop. 1981; 1(4):401-3. DOI: 10.1097/01241398-198112000-00008. View

4.
Tonner P, Scholz J, Richter A, Loscher W, Steinfath M, Wappler F . Alterations of inositol polyphosphates in skeletal muscle during porcine malignant hyperthermia. Br J Anaesth. 1995; 75(4):467-71. DOI: 10.1093/bja/75.4.467. View